194 related articles for article (PubMed ID: 28980157)
1. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous expression of cholecystokinin and gastrin receptor in stomach and pancreatic cancer: An immunohistochemical study.
Rai R; Kim JJ; Tewari M; Shukla HS
J Cancer Res Ther; 2016; 12(1):411-6. PubMed ID: 27072272
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab Inhibits Growth of HER2-Negative Gastric Cancer Cells Through Gastrin-Initialized CCKBR Signaling.
Cui Y; Li SB; Peng XC; Wu J; Fu GH
Dig Dis Sci; 2015 Dec; 60(12):3631-41. PubMed ID: 26173505
[TBL] [Abstract][Full Text] [Related]
4. Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.
Rao SV; Solum G; Niederdorfer B; Nørsett KG; Bjørkøy G; Thommesen L
BMC Cancer; 2017 Jan; 17(1):68. PubMed ID: 28109268
[TBL] [Abstract][Full Text] [Related]
5. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.
Goetze JP; Eiland S; Svendsen LB; Vainer B; Hannibal J; Rehfeld JF
Scand J Gastroenterol; 2013 Jun; 48(6):688-95. PubMed ID: 23544442
[TBL] [Abstract][Full Text] [Related]
6. Low serum gastrin associated with ER
Meng LL; Wang JL; Xu SP; Zu LD; Yan ZW; Zhang JB; Han YQ; Fu GH
BMC Cancer; 2018 Aug; 18(1):824. PubMed ID: 30115027
[TBL] [Abstract][Full Text] [Related]
7. Gastrokine 1 inhibits gastrin-induced cell proliferation.
Kim O; Yoon JH; Choi WS; Ashktorab H; Smoot DT; Nam SW; Lee JY; Park WS
Gastric Cancer; 2016 Apr; 19(2):381-391. PubMed ID: 25752269
[TBL] [Abstract][Full Text] [Related]
8. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis.
Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M
J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615
[TBL] [Abstract][Full Text] [Related]
9. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
Lloyd KA; Moore AR; Parsons BN; O'Hara A; Boyce M; Dockray GJ; Varro A; Pritchard DM
Oncotarget; 2016 Jul; 7(29):45462-45478. PubMed ID: 27323780
[TBL] [Abstract][Full Text] [Related]
10. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
11. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
[TBL] [Abstract][Full Text] [Related]
12. Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach.
Tsukamoto H; Mizoshita T; Sasaki M; Mizushima T; Tanida S; Ozeki K; Hirata Y; Shimura T; Kataoka H; Kamiya T; Nojiri S; Tsukamoto T; Tatematsu M; Joh T
Asian Pac J Cancer Prev; 2011; 12(4):1049-54. PubMed ID: 21790250
[TBL] [Abstract][Full Text] [Related]
13. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue.
Roy J; Putt KS; Coppola D; Leon ME; Khalil FK; Centeno BA; Clark N; Stark VE; Morse DL; Low PS
Oncotarget; 2016 Mar; 7(12):14605-15. PubMed ID: 26910279
[TBL] [Abstract][Full Text] [Related]
14. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.
Smith AM; Watson SA
Gut; 2000 Dec; 47(6):820-4. PubMed ID: 11076881
[TBL] [Abstract][Full Text] [Related]
15. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
16. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM
Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor.
Dickson JH; Grabowska A; El-Zaatari M; Atherton J; Watson SA
Cancer Res; 2006 Aug; 66(15):7524-31. PubMed ID: 16885350
[TBL] [Abstract][Full Text] [Related]
18. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.
Speck O; Tang W; Morgan DR; Kuan PF; Meyers MO; Dominguez RL; Martinez E; Gulley ML
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):633-45. PubMed ID: 25517873
[TBL] [Abstract][Full Text] [Related]
19. Expression of gastrin and its receptor in human gastric cancer tissues.
Hur K; Kwak MK; Lee HJ; Park DJ; Lee HK; Lee HS; Kim WH; Michaeli D; Yang HK
J Cancer Res Clin Oncol; 2006 Feb; 132(2):85-91. PubMed ID: 16228228
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of CCKBR Expression Inhibits the Proliferation of Gastric Cancer Cells, Revealing a Potential Target for Immunotoxin Therapy.
Li M; Chang J; Ren H; Song D; Guo J; Peng L; Zhou X; Zhao K; Lu S; Liu Z; Hu P
Curr Cancer Drug Targets; 2022; 22(3):257-268. PubMed ID: 34994328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
